Hy2Care (Series A)
Funding Details
Awarder
Inbox
Date Award
May 16, 2025
Vertical
Medtech
Funding Amount
$4,500,000
Company Info
Founding Year
2014
Traction
Hy2Care is preparing for a US clinical trial and commercial expansion following FDA IDE approval.
Founders
Marcel Karperien, Dr. Sanne Both
Market
Healthcare
Location
Netherlands
Coinvestors
European Innovation Council Fund, LIOF
Company Description

Hy2Care develops innovative hydrogel-based implants for repairing damaged cartilage, offering a minimally invasive treatment that supports natural tissue regeneration.

Links